[Adoptive immunotherapy using MUC1--specific CTLs for unresectable pancreatic cancer].
Kawaoka
Toru
T
Department of Surgery II, Yamaguchi University School of Medicine.
Takashima
Motonari
M
Yamamoto
Koutaro
K
Ueno
Tomio
T
Oka
Masaaki
M
D000941:Antigens / Q000627:therapeutic use*; D000951:Antigens, Neoplasm; D006023:Glycoproteins / Q000627:therapeutic use*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D018396:Mucin-1; D009077:Mucins / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000941:Antigens; D000951:Antigens, Neoplasm; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins